DeepMed Research

Takeda Pharmaceutical Company Ltd

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

Early Detection of Fabry Disease

Active, not recruiting

Conditions: Fabry Disease

Interventions: Other: No intervention

First Posted Date: 2021-11-04

Last Posted Date: 2024-11-19

Lead Sponsor: Takeda

Target Recruit Count: 50

Registration Number: NCT05106764

Locations: 🇩🇪
Universitätsmedizin Mainz Villa Metabolica Zentrum für Kinder- und Jugendmedizin, Mainz, Germany
🇩🇪
Universitätsklinikum Erlangen Kinder- und Jugendklinik, Erlangen, Germany
🇩🇪
Universitätsklinikum Erlangen Neurologische Klinik, Erlangen, Germany

Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

Recruiting

Conditions: Non-small Cell Lung Cancer (NSCLC)

Interventions: Drug: Brigatinib

First Posted Date: 2021-10-29

Last Posted Date: 2024-07-12

Lead Sponsor: Takeda

Target Recruit Count: 500

Registration Number: NCT05100069

Locations: 🇯🇵
Takeda Selected Site, Tokyo, Japan

A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Recruiting

Conditions: Hodgkin Lymphoma

Interventions: Other: No Intervention

First Posted Date: 2021-10-29

Last Posted Date: 2024-06-11

Lead Sponsor: Takeda

Target Recruit Count: 70

Registration Number: NCT05100056

Locations: 🇵🇱
Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli, Lublin, Lubelskie, Poland
🇵🇱
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Oddzial w Krakowie, Krakow, Malopolskie, Poland
🇵🇱
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Dolnoslskie, Poland

and more 10 locations

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Active, not recruiting

Conditions: Hepatocellular Cancer

Interventions: Drug: Cabozantinib

First Posted Date: 2021-10-29

Last Posted Date: 2025-05-08

Lead Sponsor: Takeda

Target Recruit Count: 263

Registration Number: NCT05100082

Locations: 🇯🇵
Takeda Selected Site, Tokyo, Japan

A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

Phase 1

Completed

Conditions: Hepatic Impairment
Healthy Volunteers

Interventions: Drug: Soticlestat

First Posted Date: 2021-10-28

Last Posted Date: 2024-02-02

Lead Sponsor: Takeda

Target Recruit Count: 36

Registration Number: NCT05098054

Locations: 🇺🇸
Velocity, Edgewater, Florida, United States
🇺🇸
GCP, Saint Petersburg, Florida, United States
🇭🇺
CRU Hungary Unit Pest Country Flor Ferenc Hospital, Kistarcsa, Hungary

and more 3 locations

A Study of Soticlestat and Rifampin in Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Soticlestat
Drug: Rifampin

First Posted Date: 2021-10-28

Last Posted Date: 2023-11-22

Lead Sponsor: Takeda

Target Recruit Count: 15

Registration Number: NCT05098041

Locations: 🇬🇧
Celerion, Belfast, United Kingdom

A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

Phase 3

Active, not recruiting

Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Multifocal Motor Neuropathy (MMN)

Interventions: Drug: TAK-771

First Posted Date: 2021-10-19

Last Posted Date: 2025-03-18

Lead Sponsor: Takeda

Target Recruit Count: 26

Registration Number: NCT05084053

Locations: 🇯🇵
Asahikawa Medical Center, Asahikawa, Hokkaido, Japan
🇯🇵
Tokushima National Hospital, Yoshinogawa, Tokushima, Japan
🇯🇵
Chiba University Hospital, Chiba, Japan

and more 20 locations

A Study Reviewing Medical Records of Adults With Helicobacter Pylori Infections in China

Completed

Conditions: Helicobacter Pylori

First Posted Date: 2021-10-11

Last Posted Date: 2023-04-18

Lead Sponsor: Takeda

Target Recruit Count: 23000

Registration Number: NCT05073367

Locations: 🇨🇳
Army Medical Center of PLA, Chongqing, Sichuan, China
🇨🇳
Zhejiang Provincial Peoples Hospital, Hangzhou, Zhejiang, China
🇨🇳
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

and more 2 locations

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Phase 1

Terminated

Conditions: Hepatocellular Cancer
Breast Cancer
Kidney Cancer
Squamous Cell Cancer of Head and Neck (SCCHN)
Non-small Cell Lung Cancer (NSCLC), Non-squamous
Gastric Cancer
Esophageal Cancer
Nasopharyngeal Cancer
Mesothelioma
Pancreatic Cancer

Interventions: Drug: TAK-500
Drug: Pembrolizumab

First Posted Date: 2021-10-07

Last Posted Date: 2025-03-07

Lead Sponsor: Takeda

Target Recruit Count: 61

Registration Number: NCT05070247

Locations: 🇺🇸
Univeristy of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
University of California San Diego, La Jolla, California, United States

and more 9 locations

A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Soticlestat
Drug: Mefenamic acid
Drug: Itraconazole

First Posted Date: 2021-10-01

Last Posted Date: 2023-10-03

Lead Sponsor: Takeda

Target Recruit Count: 28

Registration Number: NCT05064449

Locations: 🇺🇸
Celerion, Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy